The bisoprolol medication method for prevention ofatrial fibrillation coronary after cardiac surgery

The bisoprolol medication method for prevention ofatrial fibrillation coronary after cardiac surgery - The bisoprolol medication method for prevention ofatrial fibrillation coronary after cardiac surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010512

Enrollment

200

Registered

2013-04-16

Start date

2013-04-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valvular disease, angina

Interventions

preoperation preoperation and postoperation postoperation control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient who undergo valve replacement and coronary artery bypass

Exclusion criteria

Exclusion criteria: 1 heart failure, acidosis, peripheral circulatory failure, pheochromocytoma 2 LVEF<30% 3 HR<55 4 AMI(within 2 week) 5 atrial fibrillation 6 be-ta blocker(except bisoprolol) medication

Design outcomes

Primary

Measure	Time frame
atrial fibrillation	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026